Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
RF catheter ablation · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | RF ablation |
| Name | Type | Description |
|---|---|---|
| RF catheter ablation | DEVICE | RF ablation using mesh device |
Inclusion Criteria: 1. Patients who are between 18 \& 85 years of age. 2. Patients with a minimum of 2 episodes of symptomatic PAF within the last 6 months prior to baseline evaluation. At least one of these episodes must have been documented. Documentation may include electrocardiogram (ECG), tran...
RF catheter ablation is used to treat atrial fibrillation, a heart rhythm disorder. The procedure uses radiofrequency energy to create small scars in heart tissue, which can help block abnormal electrical signals that cause irregular heartbeats. It is an investigational treatment in clinical development for this condition.
RF catheter ablation is developed by Becton, Dickinson and Company, a medical technology company traded on the New York Stock Exchange under the ticker BDX. The company is conducting clinical research to evaluate the procedure for treating atrial fibrillation.
RF catheter ablation is in Phase 1 clinical development for atrial fibrillation. It is an investigational procedure and has not been approved by regulatory authorities. A Phase 1 trial has been completed to assess its safety and feasibility in patients.
RF catheter ablation has one completed clinical trial, NCT00265629, titled 'RF Ablation of Atrial Fibrillation'. This Phase 1 study enrolled 20 participants in the United States and evaluated the procedure in patients with atrial fibrillation. The trial was not randomized or blinded.
RF catheter ablation is a specific type of catheter ablation that uses radiofrequency energy to treat atrial fibrillation. While the term 'catheter ablation' can refer to various energy sources, RF catheter ablation specifically denotes the use of radiofrequency energy for this procedure.